A pathogenic hallmark of pSS is B-cell hyperactivity, reflected by the presence of autoantibodies (anti-SSA/Ro, anti-SSB/La, rheumatoid factor), hypergammaglobulinemia, and the increased risk of developing B-cell lymphoma (2). This evidence concerns the gene CALR and B-cell non-Hodgkin lymphoma.